SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-014725
Filing Date
2018-01-19
Accepted
2018-01-19 16:06:12
Documents
7
Period of Report
2018-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d525424d8k.htm 8-K 18215
2 EX-1.1 d525424dex11.htm EX-1.1 191276
3 EX-5.1 d525424dex51.htm EX-5.1 9773
4 EX-99.1 d525424dex991.htm EX-99.1 8471
5 GRAPHIC g525424g0118075305377.jpg GRAPHIC 1649
6 GRAPHIC g525424g0118080204664.jpg GRAPHIC 2805
7 GRAPHIC g525424image002.jpg GRAPHIC 6296
  Complete submission text file 0001193125-18-014725.txt   244131
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 18537435
SIC: 2834 Pharmaceutical Preparations